ArticleJTO clinical and research reports2021

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study.

Nobukazu Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.